In contrast, the NCR NKp44 can bind to platelet-derived growth factor D (PDGF-DD), which is overexpressed by many solid tumors including BLCA, and may activate NK cell antitumor functions to control tumor growth (38). This evidence concerns the gene PDGFD and neoplasm.